Skip to content
Log in
Sponsored AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI AI AM CLAUDE, A Beginner's Guide: Learn the basics of working with AI

A transcriptional signature of resting mast cells is associated with improved disease outcome in HR+HER2- breast cancer.

A. Kirchmair C. Galassi E. García-Torralba Z. Trajanoski A. Buqué Lorenzo Galluzzi
Jul 2026 · Genes and Immunity · 0 citations · 71 references
Medicine

TL;DR

Analysis of transcriptional signatures of immune cell infiltration across three public transcriptomic datasets from patients with breast cancer suggests interactions between mast cells and non-malignant components of the breast cancer microenvironment, particularly fibroblasts, may shape disease progression and treatment sensitivity.

DOI PubMed Semantic Scholar
View source

Similar papers

Open access Sep 2026

Basal-like Phenotype Identifies Immunotherapy-Responsive Subset of HR+/HER2- Breast Cancer with Aggressive Clinical Behavior

Simple Summary HR+/HER2- breast cancer represents 70% of all breast cancers but has shown limited benefit from immunotherapy, with pathological complete response (pCR) rates of only 24–30% compared to 58–66% in triple-negative breast cancer (TNBC). This resistance has been considered an immutable biological characteris...

Fang-Yu He, Yu Wu, Lu Pan et al. · 0 citations
Review Sep 2026

Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer.

BACKGROUND One-third of patients with triple-negative breast cancer (TNBC) are diagnosed with stage I tumors. Biomarkers to stratify prognosis in this setting remain a major unmet need. METHODS Tissue samples and clinicopathologic data were retrieved from consecutive patients with stage I TNBC (defined as ER <10% and...

P. Tarantino, Tian-Yu Li, Laia Paré Brunet et al. · 0 citations
Open access Aug 2026

Single-cell analyses reveal a simple multi-gene transcriptomic signature with predictive power in prognosis and therapy effectiveness in triple-negative breast cancer

Re-analysis of single-cell RNA-sequencing data characterizes the diverse cell subtypes within the tumor and microenvironment of TNBC, supporting a luminal progenitor origin for the cancer and providing clues as to the factors involved in progression of the disease.

G. Davidson, V. Debien, Tom Sexton · 0 citations
Review Open access Aug 2026

Decoding the tumor microenvironment of triple-negative breast cancer: from immune evasion to precision immunotherapy

A review summarizes the dynamic landscape of the TNBC immune microenvironment, focusing on the functional roles of tumor-infiltrating lymphocytes, tumor-associated macrophages, tumor-associated neutrophils, natural killer cells, and myeloid-derived suppressor cells in regulating antitumor immunity and therapeutic resis...

Hong-Yu Cao, Mei Tao, Xue-Yi Qin et al. · 0 citations
Open access Sep 2026

Neutrophil-related gene signature predicts prognosis and immune microenvironment patterns in thyroid cancer.

BACKGROUND Thyroid carcinoma (THCA) represents the most prevalent malignancy of the endocrine system. Although the majority of patients exhibit favorable clinical outcomes, a subset still faces significant clinical challenges, including distant metastasis, recurrence, and poor response to therapeutic interventions, all...

Liang Chen, Chao-Hon Fu, Yang Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.